tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Joseph, 158 are a BUY (60.54%), 85 are a HOLD (32.57%), 18 are a SELL (6.9%).
Analyst Eric Joseph, currently employed at CITI, carries an average stock price target met ratio of 55.39% that have a potential upside of 42.55% achieved within 187 days.
Eric Joseph’s has documented 496 price targets and ratings displayed on 53 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 19-Oct-2026.
Analyst best performing recommendations are on DTIL (PRECISION BIOSCIENCES).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 7/12/2021. The price target of $50 was fulfilled within 1 day with a profit of $1.8 (3.73%) receiving and performance score of 37.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Sep-2023
$4.5
$3.47 (336.89%)
$7.5
1 months 19 days ago
(07-Sep-2026)
15/36 (41.67%)
$3.47 (336.89%)
342
Buy Since 03-Jun-2025
$6
$4.97 (482.52%)
$6
3 months 26 days ago
(30-Jun-2026)
0/5 (0%)
$4.79 (395.87%)
Buy Since 29-Nov-2023
$4
$2.86 (250.88%)
$4
6 months 20 days ago
(07-Apr-2026)
3/7 (42.86%)
$2.62 (189.86%)
578
Buy Since 30-Mar-2022
$4
$2.86 (250.88%)
$2
8 months 21 days ago
(06-Feb-2026)
1/2 (50%)
$2.61 (187.77%)
722
Buy Since 01-Apr-2025
$6
$4.86 (426.32%)
1 years 6 months 26 days ago
(01-Apr-2025)
0/1 (0%)
$4.09 (214.14%)
Which stock is Eric Joseph most bullish on?
Which stock is Eric Joseph most reserved on?
What Year was the first public recommendation made by Eric Joseph?
